US FDA declines to approve expanded use of Alnylam's heart-disease drug

Reuters
2023.10.09 11:36
路透 10 月 9 日-Alnylam 製藥公司 (Alnylam PharmPharmticals，ALNY.O) 週一表示，美國食品和藥物管理局 (FDA) 拒絕批准擴大使用 Alnylam 製藥公司 (ALNY.O) 的藥物來治療一種罕見且致命的心臟病，理由是證據不足，無法證明其臨牀意義。
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.